Ken Fisher’s Medical Properties Trust MPT Stock Holding History

Ken Fisher’s Portfolio MPT Stock Details MPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,402	Closed	-$52K	–	1080
2025 Q4	$52K	Buy	+10,402	New	+$54.2K	﹤0.01%	1008
2023 Q4	–	Sell	-10,780	Closed	-$58.8K	–	1072
2023 Q3	$58.8K	Buy	+10,780	New	+$86.4K	﹤0.01%	1065

Other funds holding MPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Ken Fisher's MPT Position: Q1 2026 in Review

Ken Fisher sold out of Medical Properties Trust (MPT) in Q1 2026, closing a stake of 10,402 shares — an estimated $52K sold.

Ken Fisher first reported a position in MPT in Q3 2023 and held it in 2 quarters. The position peaked at $58.8K in Q3 2023. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

Ken Fisher reported no remaining Medical Properties Trust position as of Q1 2026 after selling out during the quarter.
Ken Fisher sold 10,402 Medical Properties Trust shares in Q1 2026, an estimated $52K.
Ken Fisher first reported a position in Medical Properties Trust in Q3 2023 and held it in 2 quarters.
Ken Fisher's Medical Properties Trust position peaked at $58.8K in Q3 2023.
491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.